Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism UBE2N modulators(ubiquitin conjugating enzyme E2 N modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | US | 08 Mar 2022 |